WEBSITE BSE:519105 NSE: AVT NATURAL Inc. Year: 1986 Industry: Agriculture
Last updated: 15:59
AVT Natural Products Ltd is engaged in the production of nutraceutical grade merchandise. The Company's principal products/offerings are Marigold Oleoresins, Spice Oleoresins and De-caffeinated Tea. It operates through the solvent extracted merchandise segment. It engages in contract farming in which it provides farmers with seeds. Its Marigold Oleoresin merchandise include Marigold (Food Grade) and Marigold (Feed Grade). Its Spice Oils and Oleoresins merchandise include OR paprika, OR capsicum, curcumin powder 95% and OR black pepper. Its Valu...Read More
AVT Natural Products Ltd is engaged in the production of nutraceutical grade merchandise. The Company's principal products/offerings are Marigold Oleoresins, Spice Oleoresins and De-caffeinated Tea. It operates through the solvent extracted merchandise segment. It engages in contract farming in which it provides farmers with seeds. Its Marigold Oleoresin merchandise include Marigold (Food Grade) and Marigold (Feed Grade). Its Spice Oils and Oleoresins merchandise include OR paprika, OR capsicum, curcumin powder 95% and OR black pepper. Its Value Added Tea merchandise consists of decaffeinated tea; green tea, which includes beverage grade, nutraceutical grade and application as antioxidant in meals, and instant black tea, which incorporates cold water soluble-iced tea and hot water soluble tea. Its post-harvest processing facilities are located across various locations in Tamil Nadu and Karnataka. The Company's subsidiaries comprises AVT Tea Services Ltd. And AVT Tea Services North America LLC. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹1001 Cr.
Stock P/E 20.8
P/B 1.9
Current Price ₹65.8
Book Value ₹ 34.4
Face Value 1
52W High ₹83.9
Dividend Yield 1.06%
52W Low ₹ 51
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 103 | 135 | 154 | 125 | 105 | 122 | 173 | 157 | 132 | 160 |
| Other Income | 3 | 5 | -0 | 5 | 5 | 5 | 4 | 2 | 4 | 5 |
| Total Income | 106 | 140 | 154 | 130 | 109 | 127 | 177 | 159 | 136 | 166 |
| Total Expenditure | 92 | 119 | 118 | 109 | 97 | 114 | 143 | 132 | 117 | 145 |
| Operating Profit | 14 | 22 | 36 | 20 | 13 | 13 | 34 | 27 | 20 | 20 |
| Interest | 1 | 2 | 2 | 2 | 1 | 2 | 3 | 3 | 2 | 2 |
| Depreciation | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 3 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 10 | 16 | 30 | 15 | 8 | 8 | 28 | 20 | 15 | 16 |
| Provision for Tax | 2 | 4 | 8 | 4 | 2 | 1 | 6 | 5 | 3 | 2 |
| Profit After Tax | 8 | 12 | 22 | 11 | 6 | 6 | 22 | 14 | 12 | 13 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 8 | 12 | 22 | 11 | 6 | 6 | 22 | 14 | 12 | 13 |
| Adjusted Earnings Per Share | 0.5 | 0.8 | 1.5 | 0.7 | 0.4 | 0.4 | 1.4 | 0.9 | 0.8 | 0.9 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 261 | 274 | 311 | 328 | 339 | 396 | 485 | 559 | 582 | 517 | 556 | 622 |
| Other Income | 4 | 2 | 5 | 13 | 4 | 7 | 8 | 10 | 2 | 13 | 16 | 15 |
| Total Income | 265 | 276 | 316 | 341 | 343 | 403 | 494 | 570 | 585 | 530 | 572 | 638 |
| Total Expenditure | 215 | 236 | 269 | 295 | 297 | 339 | 414 | 454 | 461 | 438 | 486 | 537 |
| Operating Profit | 50 | 41 | 47 | 46 | 46 | 64 | 80 | 116 | 123 | 92 | 86 | 101 |
| Interest | 4 | 1 | 2 | 3 | 5 | 6 | 4 | 5 | 5 | 7 | 9 | 10 |
| Depreciation | 6 | 6 | 7 | 7 | 11 | 14 | 15 | 14 | 13 | 14 | 14 | 13 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 41 | 33 | 38 | 36 | 30 | 45 | 61 | 97 | 105 | 71 | 63 | 79 |
| Provision for Tax | 14 | 11 | 14 | 12 | 9 | 11 | 15 | 24 | 27 | 18 | 15 | 16 |
| Profit After Tax | 26 | 22 | 24 | 24 | 21 | 34 | 45 | 73 | 77 | 53 | 48 | 61 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 26 | 22 | 24 | 24 | 21 | 34 | 45 | 73 | 77 | 53 | 48 | 61 |
| Adjusted Earnings Per Share | 1.7 | 1.4 | 1.6 | 1.6 | 1.4 | 2.2 | 3 | 4.8 | 5.1 | 3.5 | 3.2 | 4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 8% | -0% | 7% | 8% |
| Operating Profit CAGR | -7% | -9% | 6% | 6% |
| PAT CAGR | -9% | -13% | 7% | 6% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -7% | -15% | 7% | 8% |
| ROE Average | 10% | 14% | 16% | 13% |
| ROCE Average | 13% | 18% | 20% | 18% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 186 | 200 | 224 | 238 | 252 | 275 | 310 | 369 | 430 | 470 | 506 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 16 | 11 | 8 | 5 | 8 | 5 | 3 |
| Other Non-Current Liabilities | 6 | 7 | 12 | 11 | 10 | 10 | 10 | 8 | 7 | 11 | 9 |
| Total Current Liabilities | 45 | 42 | 39 | 80 | 111 | 82 | 98 | 67 | 77 | 113 | 228 |
| Total Liabilities | 237 | 249 | 275 | 330 | 389 | 378 | 426 | 449 | 522 | 598 | 747 |
| Fixed Assets | 53 | 58 | 57 | 56 | 98 | 99 | 89 | 82 | 78 | 82 | 72 |
| Other Non-Current Assets | 3 | 3 | 10 | 50 | 7 | 6 | 4 | 4 | 3 | 6 | 12 |
| Total Current Assets | 181 | 189 | 208 | 224 | 283 | 272 | 333 | 362 | 441 | 511 | 663 |
| Total Assets | 237 | 249 | 275 | 330 | 389 | 378 | 426 | 449 | 522 | 598 | 747 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 13 | 12 | 8 | 11 | 7 | 10 | 17 | 14 | 14 | 20 | 25 |
| Cash Flow from Operating Activities | 12 | 34 | 16 | 14 | -30 | 71 | 8 | 74 | 51 | 99 | -32 |
| Cash Flow from Investing Activities | 0 | -31 | -10 | -29 | 4 | -14 | -4 | -29 | -37 | -73 | -9 |
| Cash Flow from Financing Activities | -12 | -7 | -3 | 11 | 29 | -50 | -6 | -45 | -9 | -20 | 50 |
| Net Cash Inflow / Outflow | -1 | -4 | 3 | -4 | 3 | 7 | -3 | 0 | 6 | 5 | 8 |
| Closing Cash & Cash Equivalent | 12 | 8 | 11 | 7 | 10 | 17 | 14 | 14 | 20 | 25 | 34 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.73 | 1.42 | 1.61 | 1.59 | 1.37 | 2.23 | 2.97 | 4.78 | 5.08 | 3.5 | 3.17 |
| CEPS(Rs) | 2.11 | 1.83 | 2.07 | 2.06 | 2.08 | 3.13 | 3.97 | 5.73 | 5.96 | 4.41 | 4.08 |
| DPS(Rs) | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.7 | 1 | 1 | 0.8 | 0.7 |
| Book NAV/Share(Rs) | 12.23 | 13.16 | 14.72 | 15.65 | 16.52 | 18.05 | 20.37 | 24.22 | 28.26 | 30.83 | 33.25 |
| Core EBITDA Margin(%) | 17.75 | 14.2 | 13.48 | 9.93 | 12.3 | 14.4 | 14.65 | 18.8 | 20.66 | 15.25 | 12.54 |
| EBIT Margin(%) | 16.97 | 12.51 | 12.84 | 11.69 | 10.3 | 12.7 | 13.28 | 18.06 | 18.77 | 14.99 | 12.95 |
| Pre Tax Margin(%) | 15.5 | 12.04 | 12.32 | 10.91 | 8.8 | 11.3 | 12.45 | 17.24 | 17.86 | 13.65 | 11.26 |
| PAT Margin (%) | 10.09 | 7.88 | 7.84 | 7.37 | 6.15 | 8.58 | 9.31 | 12.99 | 13.22 | 10.24 | 8.6 |
| Cash Profit Margin (%) | 12.28 | 10.12 | 10.08 | 9.56 | 9.35 | 12.04 | 12.44 | 15.55 | 15.51 | 12.9 | 11.07 |
| ROA(%) | 11.14 | 8.9 | 9.32 | 8 | 5.8 | 8.87 | 11.28 | 16.66 | 15.95 | 9.52 | 7.17 |
| ROE(%) | 14.91 | 11.19 | 11.52 | 10.47 | 8.51 | 12.92 | 15.48 | 21.46 | 19.37 | 11.84 | 9.88 |
| ROCE(%) | 24.23 | 17.05 | 17.81 | 14.93 | 11.51 | 15.5 | 19.07 | 26.97 | 25.7 | 16.07 | 12.95 |
| Receivable days | 55.02 | 62.13 | 62.8 | 66.04 | 78.11 | 72.33 | 66.72 | 66.58 | 69.69 | 81.12 | 86.7 |
| Inventory Days | 122.11 | 108.92 | 97.85 | 104.11 | 127.93 | 122.59 | 107.6 | 113.1 | 123.26 | 151.87 | 167.61 |
| Payable days | 49.49 | 28.75 | 31.75 | 51.8 | 82.31 | 54.89 | 47.31 | 49.73 | 47.71 | 71.69 | 116.45 |
| PER(x) | 15.61 | 19.72 | 24.51 | 22.65 | 19.29 | 10.59 | 15.13 | 27.29 | 15.57 | 23.96 | 17.05 |
| Price/Book(x) | 2.21 | 2.13 | 2.67 | 2.3 | 1.6 | 1.31 | 2.21 | 5.39 | 2.8 | 2.72 | 1.62 |
| Dividend Yield(%) | 1.85 | 1.43 | 1.02 | 1.11 | 1.52 | 2.54 | 1.56 | 0.77 | 1.26 | 0.95 | 1.3 |
| EV/Net Sales(x) | 1.54 | 1.55 | 1.93 | 1.75 | 1.39 | 0.97 | 1.48 | 3.56 | 2.09 | 2.48 | 1.61 |
| EV/Core EBITDA(x) | 8.06 | 10.48 | 12.8 | 12.63 | 10.3 | 5.98 | 9.02 | 17.24 | 9.87 | 13.98 | 10.34 |
| Net Sales Growth(%) | -10.73 | 5.04 | 13.41 | 5.36 | 3.4 | 16.88 | 22.38 | 15.31 | 4.07 | -11.15 | 7.5 |
| EBIT Growth(%) | -36.15 | -22.52 | 16.51 | -4.18 | -8.92 | 44.08 | 28.21 | 56.86 | 8.51 | -28.99 | -6.93 |
| PAT Growth(%) | -37.29 | -18.04 | 13.05 | -0.99 | -13.9 | 63.13 | 33.2 | 60.85 | 6.24 | -31.15 | -9.5 |
| EPS Growth(%) | -37.29 | -18.04 | 13.05 | -0.98 | -13.9 | 63.13 | 33.2 | 60.85 | 6.24 | -31.15 | -9.5 |
| Debt/Equity(x) | 0.04 | 0.05 | 0.07 | 0.15 | 0.32 | 0.15 | 0.16 | 0.06 | 0.08 | 0.08 | 0.22 |
| Current Ratio(x) | 4.02 | 4.46 | 5.35 | 2.79 | 2.56 | 3.32 | 3.4 | 5.39 | 5.75 | 4.53 | 2.9 |
| Quick Ratio(x) | 2.02 | 2.71 | 2.94 | 1.62 | 1.26 | 1.83 | 1.72 | 2.66 | 2.98 | 2.57 | 1.62 |
| Interest Cover(x) | 11.52 | 26.66 | 24.83 | 15.13 | 6.87 | 9.06 | 16.11 | 21.93 | 20.52 | 11.21 | 7.65 |
| Total Debt/Mcap(x) | 0.02 | 0.02 | 0.03 | 0.07 | 0.2 | 0.12 | 0.07 | 0.01 | 0.03 | 0.03 | 0.13 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 0.05 | 0.02 | 0.15 | 0.05 | 0.06 | 0.06 | 0.09 | 0.07 | 0.06 | 0.04 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.11 | 0.11 | 0.23 | 0.23 |
| Public | 24.93 | 24.96 | 24.83 | 24.94 | 24.92 | 24.92 | 24.8 | 24.83 | 24.71 | 24.73 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 | 11.42 |
| FII | 0.01 | 0 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0.02 | 0.04 | 0.04 |
| Public | 3.8 | 3.8 | 3.78 | 3.8 | 3.79 | 3.79 | 3.78 | 3.78 | 3.76 | 3.77 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 | 15.23 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
